^
    2ms
    Ambry Genetics Announces New Hereditary Cancer Test Menu at NSGC Annual Conference (Businesswire)
    "Ambry Genetics...announced enhancements to their portfolio of tests for the detection of genetic mutations associated with hereditary cancer. This new evidence-informed menu builds on the company’s 12-year history in hereditary cancer testing, to offer tests reflecting the latest scientific evidence and national consensus guidelines....Ambry will be featuring the enhancements to their hereditary cancer portfolio at the National Society of Genetic Counselors (NSGC) 2024 Annual Conference in New Orleans, Louisiana, from September 17 – 21. A symposium on 'Designing and Selecting Effective Panels for Maximized Clinical Utility' will be held by Ambry during the conference."
    Clinical
    |
    BRCANext® • CancerNext ® • ColoNext®